Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping

[Image: see text] FLT3 kinase is a potential drug target in acute myeloid leukemia (AML). Patients with FLT3 mutations typically have higher relapse rates and worse outcomes than patients without FLT3 mutations. In this study, we investigated the suitability of various heterocycles as central cores...

Descripción completa

Detalles Bibliográficos
Autores principales: Břehová, Petra, Řezníčková, Eva, Škach, Kryštof, Jorda, Radek, Dejmek, Milan, Vojáčková, Veronika, Šála, Michal, Kovalová, Markéta, Dračínský, Martin, Dolníková, Alexandra, Strmeň, Timotej, Kinnertová, Monika, Chalupský, Karel, Dvořáková, Alexandra, Gucký, Tomáš, Mertlíková Kaiserová, Helena, Klener, Pavel, Nencka, Radim, Kryštof, Vladimír
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461230/
https://www.ncbi.nlm.nih.gov/pubmed/37535845
http://dx.doi.org/10.1021/acs.jmedchem.3c00575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461230/
https://www.ncbi.nlm.nih.gov/pubmed/37535845
http://dx.doi.org/10.1021/acs.jmedchem.3c00575

Ejemplares similares